Basoglu, F. Et Al. 2021. Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation. CHEMICAL BIOLOGY & DRUG DESIGN , vol.98, no.2 , 270-282.

Basoglu, F., Ulusoy-Guzeldemirci, N., AKALIN ÇİFTÇİ, G., ÇETİNKAYA, S., & Ece, A., (2021). Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation. CHEMICAL BIOLOGY & DRUG DESIGN , vol.98, no.2, 270-282.

Basoglu, Faika Et Al. "Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation," CHEMICAL BIOLOGY & DRUG DESIGN , vol.98, no.2, 270-282, 2021

Basoglu, Faika Et Al. "Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation." CHEMICAL BIOLOGY & DRUG DESIGN , vol.98, no.2, pp.270-282, 2021

Basoglu, F. Et Al. (2021) . "Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation." CHEMICAL BIOLOGY & DRUG DESIGN , vol.98, no.2, pp.270-282.

@article{article, author={Faika Basoglu Et Al. }, title={Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation}, journal={CHEMICAL BIOLOGY & DRUG DESIGN}, year=2021, pages={270-282} }